Zobrazeno 1 - 6
of 6
pro vyhledávání: '"T. N. Latief"'
Publikováno v:
JNCI Journal of the National Cancer Institute. 80:1147-1151
A total of 218 postmenopausal patients were entered in a prospective randomized trial comparing aminoglutethimide (AG) and high-dose medroxyprogesterone acetate (MPA) as second-line hormonal therapy for advanced breast carcinoma. All responses were a
Autor:
A.C Williams, Mould Jj, L Honigsberger, S.R Jones, D.R Blake, David Spooner, G. R. P. Blackledge, T. N. Latief, C.A Mfanwell, A.E Blake, Ian C. Shaw
Publikováno v:
Lancet (London, England). 1(8425)
Autor:
C A, Meanwell, J J, Mould, G, Blackledge, F G, Lawton, N S, Stuart, J, Kavanagh, T N, Latief, D, Spooner, A D, Chetiyawardana
Publikováno v:
Cancer treatment reports. 70(6)
Thirty patients with symptomatic, progressive squamous cell carcinoma of the uterine cervix no longer amenable to surgery or radiotherapy were entered in a phase II study of ifosfamide (IFX). Patients were treated with IFX (5 g/m2 iv given over 24 ho
Publikováno v:
Seminars in oncology. 12(1 Suppl 2)
Thirty-three ambulatory patients with limited stage, inoperable, squamous cell carcinoma of the bronchus were administered cisplatin (60 mg/m2 IV on day 1) and etoposide (VP-16) (400 mg/m2 orally in divided doses over days 3, 4, and 5). This regimen
Autor:
C.W. Redman, M. Paterson, C. Hilton, D. M. Luesley, Chetiyawardana Ad, J. J. Mould, C. A. Meanwell, E. J. Buxton, T. N. Latief, David Spooner, G.R.P. Blackledge
Publikováno v:
Journal of the National Cancer Institute. 81(5)
We report a phase II study of bleomycin, ifosfamide, and cisplatin (BIP) in cervical cancer. Our aims were to assess response rate, toxicity, and survival in women treated with this combination. Among 49 patients, 34 objective responses (69%) were se
Publikováno v:
European journal of cancerclinical oncology. 22(9)
Thirty-seven patients with advanced breast cancer were treated with megestrol acetate 160 mg daily. All patients except two had been heavily pre-treated with hormonal therapy; eight patients also received chemotherapy. Complete and partial responses